[
  {
    "trial_id": "ASCENT-05",
    "name": "ASCENT-05",
    "cancer_type": "Breast",
    "inclusion_criteria": {
      "age_min": 18,
      "ecog_max": 1,
      "diagnosis": ["HER2+ Breast Cancer"],
      "staging": ["Stage II", "Stage III"],
      "prior_treatment": ["Neoadjuvant Chemotherapy"],
      "measurable_disease": true
    },
    "exclusion_criteria": {
      "prior_treatment_lines": ">2",
      "comorbidities": ["Uncontrolled hypertension", "Active infection"],
      "mutations_excluded": []
    }
  },
  {
    "trial_id": "MajesTEC-4",
    "name": "MajesTEC-4",
    "cancer_type": "Multiple Myeloma",
    "inclusion_criteria": {
      "age_min": 18,
      "ecog_max": 2,
      "diagnosis": ["Relapsed/Refractory Multiple Myeloma"],
      "staging": ["ISS Stage II", "ISS Stage III"],
      "prior_treatment": ["At least 1 prior line of therapy"],
      "genetics_required": []
    },
    "exclusion_criteria": {
      "prior_treatment_lines": ">6",
      "comorbidities": ["Cardiac failure NYHA III/IV", "CNS involvement"]
    }
  }
]
